Cronos Group Announces Appointment of Jody Begley to Board of Directors
September 30 2019 - 12:01PM
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the
“Company”) today announced that, in connection with its investment
in the Company, Altria Group, Inc. (“Altria”) has appointed Jody
Begley to the Cronos Group Board of Directors. Mr. Begley is
currently Senior Vice President, Tobacco Products for Altria Group
in which he oversees more than $24 billion in net revenues.
Altria’s appointment replaces one of its previous director
designees, K.C. Crosthwaite, who has resigned from the Cronos Group
Board to devote more time to his new position as CEO of JUUL Labs.
Prior to Mr. Begley’s current role, he served as
President and General Manager of Nu Mark, leading the company's
development and marketing of innovative tobacco products for adult
smokers and vapers. He joined Philip Morris USA in 1995 and has
held various leadership positions at several Altria companies,
including Vice President, Brand Management, PM USA; Vice President,
Strategy & Business Development; Vice President, Marketing
& Promotion Services; Vice President, Brand Management,
Smokeless; and Vice President, Customer & Marketing
Services.
About Cronos Group Inc.Cronos Group is an
innovative global cannabinoid company with international production
and distribution across five continents. Cronos Group is
committed to building disruptive intellectual property by
advancing cannabis research, technology and product
development. With a passion to responsibly elevate the
consumer experience, Cronos Group is building an iconic brand
portfolio. Cronos Group’s portfolio includes PEACE
NATURALS™, a global health and wellness platform, two
adult-use brands, COVE™ and Spinach™, and Lord Jones™, a
hemp-derived cannabidiol (CBD) personal care brand. To learn
more about Cronos Group and its brands, please
visit: www.thecronosgroup.com; www.peacenaturals.com; www.covecannabis.ca; www.spinachcannabis.com;
www.lordjones.com
Forward-Looking Statements This news release
contains “forward‐looking information” and “forward‐looking
statements” within the meaning of applicable Canadian and U.S.
securities laws. All information contained herein that is not
clearly historical in nature may constitute forward‐looking
information. In some cases, forward‐looking statements can be
identified by words or phrases such as “may”, “will”, “expect”,
“plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe”
or the negative of these terms, or other similar expressions
intended to identify forward‐looking statements. Some of the
forward‐looking statements contained in this press release include
the anticipated benefits of the acquisition, the ability of the
Company to continue, consistent with applicable law, to develop,
manufacture, distribute and sell hemp‐based products in the United
States and internationally, the Company’s intention to build an
international iconic brand portfolio and develop disruptive
intellectual property. Forward‐looking statements are
necessarily based upon a number of estimates and assumptions that,
while considered reasonable by management, are inherently subject
to significant business, economic and competitive risks,
uncertainties and contingencies that may cause actual
financial results, performance or achievements to be materially
different from the estimated future results, performance or
achievements expressed or implied by those forward‐looking
statements and the forward‐looking statements are not guarantees of
future performance. A discussion of some of the material
risks applicable to the Company can be found in the Company’s
current Management’s Discussion and Analysis and Annual Information
Form, both of which have been filed on SEDAR and EDGAR and can be
accessed at www.sedar.com and www.sec.gov/edgar,
respectively. The forward‐looking information included in
this news release is made as of the date of this news release and,
except as required by law, Cronos Group disclaims any obligation to
update or revise any forward‐ looking statements. Readers are
cautioned not to put undue reliance on these forward‐looking
statements.
Cronos Group ContactAnna ShlimakTel: (416)
504-0004investor.relations@thecronosgroup.com
Cronos (TSX:CRON)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cronos (TSX:CRON)
Historical Stock Chart
From Jul 2023 to Jul 2024